Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics.
about
Model-based design of growth-attenuated virusesRecombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzeesEffect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokinesComparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage.Recombinant bovine/human parainfluenza virus type 3 (B/HPIV3) expressing the respiratory syncytial virus (RSV) G and F proteins can be used to achieve simultaneous mucosal immunization against RSV and HPIV3.Recombinant respiratory syncytial viruses lacking the C-terminal third of the attachment (G) protein are immunogenic and attenuated in vivo and in vitro.Animal pneumoviruses: molecular genetics and pathogenesis.Recombinant respiratory syncytial virus with the G and F genes shifted to the promoter-proximal positionsBiological challenges and technological opportunities for respiratory syncytial virus vaccine development.A comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infectionRecovery of avian metapneumovirus subgroup C from cDNA: cross-recognition of avian and human metapneumovirus support proteins.Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics.Immunoprophylaxis of respiratory syncytial virus: global experience.Mammalian Cell-Derived Respiratory Syncytial Virus-Like Particles Protect the Lower as well as the Upper Respiratory TractRecovery of human metapneumovirus genetic lineages a and B from cloned cDNA.The human respiratory syncytial virus nonstructural protein 1 regulates type I and type II interferon pathways.Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokines.Generation of recombinant human parainfluenza virus type 1 vaccine candidates by importation of temperature-sensitive and attenuating mutations from heterologous paramyxoviruses.Deletion of nonstructural proteins NS1 and NS2 from pneumonia virus of mice attenuates viral replication and reduces pulmonary cytokine expression and diseaseThe absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines.Respiratory syncytial virus vaccine: Is it coming?Analysis of the noncoding regions of measles virus strains in the Edmonston vaccine lineage.Rational attenuation of a morbillivirus by modulating the activity of the RNA-dependent RNA polymerase.A highly attenuated recombinant human respiratory syncytial virus lacking the G protein induces long-lasting protection in cotton rats.Replication and clearance of respiratory syncytial virus: apoptosis is an important pathway of virus clearance after experimental infection with bovine respiratory syncytial virus
P2860
Q33256104-4DCE29A7-8AFC-4E0A-A41E-4F5AE702AD31Q33605207-D2B00868-D3E2-4962-A70B-C61FFFDDCE6CQ33809197-5E91DAA3-0B85-4F0A-AB2F-26ECFD1261B6Q33835693-A5F71614-1FD3-46F3-A50F-21385F367B33Q33840469-FD7F0370-6392-4D30-B039-1EB155B15011Q34151865-A9CF9030-073C-4ECD-9D27-8D8304C664BCQ34313560-9F987848-D108-4F2E-9DA2-767F684B9EC2Q34359826-9F63B811-48FC-4762-A3F6-29453BDC6E54Q34504791-24B8DF01-B73A-4414-B59E-DAE7379A3E7EQ34634867-8EAB6283-70FF-4D95-B144-B3C6A80715F6Q34651310-EDE0628A-26EC-43A3-B711-88069E437B66Q34717853-370FE975-A2AB-4836-A022-BFF2621EC680Q34740842-1500CB22-2ECD-4B50-9455-70C7594DFF8DQ35690781-57C405C1-146E-42FE-A04F-26F2AD1CD371Q35705123-88B76DB0-C12B-4890-A0E7-07A3F126D246Q36163501-F81F2121-2AD8-457F-B932-48C2D10C7DFFQ36957257-E85D4523-CF75-4C20-AEEB-2E38E342964CQ36961947-D7291184-D6F4-4FAC-8AD8-64B606C4EFC5Q37099834-BDB2A483-FA53-473B-8A41-9300851394A2Q37384009-52A612ED-FE01-43BD-9927-AE8CD940DE83Q37481336-CC64EAE7-CCDB-4B1F-B530-97584264C549Q39601579-6068E058-C8DE-43F9-A529-59DE09762F7FQ39612879-C19C3116-F8B5-4B28-912F-01A8E6CFC596Q39696619-9FFD59DB-9B8C-490C-A4F5-5DE1906A5982Q42855455-960DD160-6BAA-4FCA-B9AC-DB6203CB96B2
P2860
Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Rational design of live-attenu ...... ial virus by reverse genetics.
@ast
Rational design of live-attenu ...... ial virus by reverse genetics.
@en
type
label
Rational design of live-attenu ...... ial virus by reverse genetics.
@ast
Rational design of live-attenu ...... ial virus by reverse genetics.
@en
prefLabel
Rational design of live-attenu ...... ial virus by reverse genetics.
@ast
Rational design of live-attenu ...... ial virus by reverse genetics.
@en
P2093
P1476
Rational design of live-attenu ...... tial virus by reverse genetics
@en
P2093
Bukreyev A
Chanock RM
Collins PL
Whitehead SS
P304
P577
1999-01-01T00:00:00Z